Burton Paul Frederick has exercised stock options, acquiring 3,286 shares of Cardio Diagnostics Holdings, Inc. This transaction, reported on October 2, 2026, is significant as it reflects Frederick's ongoing commitment to the company and its future growth.
Cardio Diagnostics Holdings, Inc. operates in the in vitro and in vivo diagnostic substances sector. The company, which trades under the ticker CDIO, is based in Chicago, Illinois. Its focus on innovative diagnostic solutions positions it well within a competitive industry.
The filing indicates that the stock options were exercised at a price of $1.90 per share, with the transaction date noted as September 30, 2026. Following this transaction, Frederick now owns a total of 16,607 shares of the company.
This development may affect stakeholders within Cardio Diagnostics, including employees, investors, and competitors. As the diagnostics industry evolves, such actions by leadership can signal confidence and potentially influence market perceptions.
The filing does not say what happens next.
Details of the Stock Options
The stock options exercised by Burton Paul Frederick were acquired at a price of $1.90 per share. The transaction was executed on September 30, 2026, and the options have an expiration date of September 30, 2036, providing Frederick with a long-term opportunity to benefit from the company's performance.
Ownership and Position
Following this transaction, Frederick's total ownership in Cardio Diagnostics Holdings, Inc. has increased to 16,607 shares. Notably, he holds a direct ownership stake, indicating a personal investment in the company's future. Additionally, the filing confirms that Frederick serves as a director of the company, which may further align his interests with those of the shareholders.
"The exercise of stock options by a director can often be seen as a positive signal regarding the company's prospects."
Company Background
Cardio Diagnostics Holdings, Inc. operates within the in vitro and in vivo diagnostic substances sector, classified under the Standard Industrial Classification of 2835. The company is incorporated in Delaware and has its business address in Chicago, Illinois, where it continues to develop innovative diagnostic solutions.
Future Considerations
While the filing provides insights into Frederick's recent stock option exercise, it does not include any information regarding future plans or strategies from Cardio Diagnostics Holdings, Inc. or any potential impacts on the company's stock performance or market strategy.